In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $445.00. The company’s shares ...

BofA raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $567 from $555 and keeps a Buy rating on the shares. After having surveyed 35 key opinion leaders who treat a total of ...

A Top 10 list outlining the 10 most iconic car logos, including their genesis, their history, and their evolution though the ...

and in 1992 the company started sellling cars in North America. Today it is the second-largest automaker in South Korea, right behind Hyundai. There are several brands, however, whose logos hold a ...

President Donald Trump has made clear he wants more American-made cars, between plans for a 25% auto tariff and a proposal for tax-deductible interest on loans for cars made in the U.S., but none ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Jonathan Ward is widely considered one of the best in the business for restomods, and he's now turning his eyes to electrification.

A car is an expensive purchase, but choosing the right lender can save you thousands of dollars in interest charges and fees. Plus, you want your car shopping experience to be easy and transparent ...

The latest car news, videos and expert reviews, from Cars.com's independent automotive journalists We’ve compared hundreds of models and thousands of configurations to find the cars that give ...

Scorpio N is beast in the segment but every car has its own pros and cons, Scorpio is not a title to ...